These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
44. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it? Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873 [TBL] [Abstract][Full Text] [Related]
45. Effect of biphasic shock duration on defibrillation threshold with different electrode configurations and phase 2 capacitances: prediction by upper-limit-of-vulnerability determination. Schauerte PN; Ziegert K; Waldmann M; Schöndube FA; Birkenhauer F; Mischke K; Grossmann M; Hanrath P; Stellbrink C Circulation; 1999 Mar; 99(11):1516-22. PubMed ID: 10086978 [TBL] [Abstract][Full Text] [Related]
46. Effect of waveform tilt on defibrillation thresholds in humans. Shorofsky SR; Foster AH; Gold MR J Cardiovasc Electrophysiol; 1997 May; 8(5):496-501. PubMed ID: 9160225 [TBL] [Abstract][Full Text] [Related]
47. Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system. Souza JJ; Malkin RA; Ideker RE Circulation; 1995 Feb; 91(4):1247-52. PubMed ID: 7850965 [TBL] [Abstract][Full Text] [Related]
48. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs. Swerdlow CD; Shehata M; Chen PS Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725 [TBL] [Abstract][Full Text] [Related]
49. Defibrillation waveform duration adjustment increases the proportion of acceptable defibrillation thresholds in patients implanted with single-coil defibrillation leads. Gabriels J; Budzikowski AS; Kassotis JT Cardiology; 2013; 124(2):71-5. PubMed ID: 23363780 [TBL] [Abstract][Full Text] [Related]
50. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators. Martin DJ; Chen PS; Hwang C; Gang ES; Mandel WJ; Peter CT; Swerdlow CD J Cardiovasc Electrophysiol; 1997 Mar; 8(3):241-8. PubMed ID: 9083873 [TBL] [Abstract][Full Text] [Related]
52. Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors. Gurevitz OT; Friedman PA; Glikson M; Trusty JM; Ballman KV; Rosales AG; Hayes DL; Hammill SC; Swerdlow CD J Cardiovasc Electrophysiol; 2003 Jul; 14(7):728-32. PubMed ID: 12930253 [TBL] [Abstract][Full Text] [Related]
53. Low-tilt monophasic and biphasic waveforms compared with standard biphasic waveforms in the transvenous defibrillation of ventricular fibrillation. Bennett JR; Darragh KM; Walsh SJ; Allen DJ; Scott M; Stevenson M; Adgey JA; Anderson JM; Manoharan G Pacing Clin Electrophysiol; 2014 Mar; 37(3):279-89. PubMed ID: 24102186 [TBL] [Abstract][Full Text] [Related]
55. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators. Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of shock waveform configuration on the defibrillation capacity of implantable cardioverter defibrillators in dogs. Pariaut R; Saelinger C; Vila J; Deforge W; Queiroz-Williams P; Beaufrère H; Zimmerman M; Saile K; Reynolds CA J Vet Cardiol; 2012 Sep; 14(3):389-98. PubMed ID: 22819488 [TBL] [Abstract][Full Text] [Related]
57. Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves. Malkin RA; Idriss SF; Walker RG; Ideker RE Circulation; 1995 Sep; 92(5):1291-9. PubMed ID: 7648678 [TBL] [Abstract][Full Text] [Related]
58. Predictors of successful defibrillation threshold test during CRT-D implantation. Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010 [TBL] [Abstract][Full Text] [Related]